Your Article Summary
See Latest ArticlesInsulin detemir alert issued by FDA
American Pharmacists Association, 06/15/09
FDA announced that some stolen vials of the basal insulin product Levemir have reappeared and are being sold on the U.S. market. Pharmacists should remove vials with the following lot numbers of this insulin detemir product from inventory: XZF0036, XZF0037, and XZF0038. One report of a patient who suffered an adverse event due to poor control of glucose levels after using a vial from one of these three lots has been reported to FDA.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
The Unintended Consequences of Clinical Trials Regulations
PLoS Medicine, 12/04/09
Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
PLoS Medicine, 12/02/09
FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09